We also demonstrate that RCT elicits anti-tumor immune responses, including the recruitment of CD16+ NK cells with higher cytotoxic gene expression and FCN1+ M-MDSC cells with increased pro-inflammatory features. Here, FCN1 is linked to neoplasm.